Session: Nanomedicine and Drug Delivery II (2010 Annual Meeting)

Description:

Advances in nanotechnology hold significant promise to play vital roles in the diagnostic and treatment of human disease. This session is focused on advances of nanotechnology for drug delivery applications.

Sponsor:

Topical F: Nanotechnology in Medicine

Co-Sponsor(s):

Food, Pharmaceutical & Bioengineering Division (15), Nanoscale Science and Engineering Forum (22)

Chair:

Hamid Ghandahari
Professor
University of Utah
Pharmaceutics & Pharmaceutical Chemistry
383 Colorow Dr Rm 343
Salt Lake City, UT 84112
Phone Number: 801-587-1566
Email: hamid.ghandehari@pharm.utah.edu

Co-Chair:

Leonard F. Pease III
Assistant Professor of Chemical Engineering
University of Utah
Chemical Engineering and Pharmaceutics & Pharmaceutical Chemistry
50 S. Central Campus Drive, 3290 MEB
Salt Lake City, UT 84112
Phone Number: 801-585-2284
Fax Number: 801-585-9291
Email: pease@eng.utah.edu

Papers:

480a

Merging ‘Micro' with ‘Nano': On-Chip High-Throughput Synthesis of Polymeric Nanoparticles for Cancer Therapy
Pedro M. Valencia, MIT; Minsoung Rhee, MIT; Robert Langer, MIT; Omid C. Farokhzad, Harvard Medical School; Rohit Karnik, MIT

480b

Fabrication of Highly Uniform Nanoparticles From Recombinant Silk-Elastinlike Protein Polymers for Gene Delivery Applications
Rajasekhar Anumolu, University of Utah; Joshua Gustafson, University of Utah; Hamid Ghandehari, University of Utah; Leonard F. Pease III, University of Utah

480c

Formation and Drug Release From Particles Produced Via Flash Nanoprecipitation
Zhengxi Zhu, University of Minnesota; Han Jing, University of Minnesota; Adam Wohl, University of Minnesota; Thomas Hoye, University of Minnesota; Christopher W. Macosko, University of Minnesota

480d

Stabilization of the Nitric Oxide Prodrugs through Incorporation Into PEG-Protected Nanoparticles
Varun Kumar, Princeton University; Harinath Chakrapani, Indian Institute of Science Education and Research; Sam Y. Hong, National Cancer Institute at Frederick; Anna E. Maciag, SAIC - Frederick , Inc.; Joseph E. Saavedra, SAIC - Frederick , Inc.; Larry K. Keefer, National Cancer Institute at Frederick; Robert K. Prud'homme, Princeton University

480e

Anti-Cancer Nanoparticle Synthesis and Characterization
Fan Mei, Brookhaven National Laboratory; Da-Ren Chen, Washington University; Yin-Nan Lee, Brookhaven National Laboratory

480f

Doxorubicin- Loaded Albumin Nanoparticles: Formulation and Characterization
Parvin Golbayani, Tennessee Technological University; Soheyla Honary, Mazandaran University of Medical Sciences; Mohsen Jahanshahi, Babol Noshirvani University of Technology; Pouneh Ebrahimi, Gorgan University of Agricultural Sciences& Natural Resources

480g

A New Charge Reversal PCL-Block-Polyhistidine Nanoprticles for Nuclear Targeting Drug Delivery
Erlei Jin Sr., University of Wyoming; Bo Zhang, University of Wyoming; Jianbin Tang, Zhejiang University; Maohong Fan, University of Wyoming; Huadong Tang, Department of Chemical and Petroleum Engineering, University of Wyoming; Maciej Radosz, University of Wyoming; Edward A. Van Kirk, Department of Animal Science, University of Wyoming; William J. Murdoch, Department of Animal Science, University of Wyoming; Youqing Shen, Zhejiang University

See more of this Group/Topical: Topical F: Nanotechnology in Medicine

<< Previous Session | Next Session >>